Huhtamaki India DuPont analysis

·OthersChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Dec 2025FY25Dec 2024FY24Dec 2023FY23Dec 2022FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.74×0.75×0.75×0.82×0.89×
1.06×1.14×1.67×3.44×0.79×
6.0%5.6%2.8%5.7%2.4%
1.25×1.25×1.28×1.36×1.68×
1.55×1.55×1.62×1.74×2.31×
9.1%9.3%7.2%38.0%6.5%
9.5%9.5%7.5%43.0%6.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

HUHTAMAKI₹239.35

Huhtamaki India Limited

· Others
₹ CrorePeersMOLDTKPACCOSMOFIRSTXPROINDIAJINDALPOLYTCPLPACKCOMSYNPOLYPLEXDVLMcap ₹1,808 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.890.820.750.750.74
Interest Burden (Pretax/EBIT) ×0.793.441.671.141.06
EBIT Margin %2.385.712.775.625.95
Asset Turnover ×1.681.361.281.251.25
Financial Leverage (Assets/Equity) ×2.311.741.621.551.55
ROE (5-step product, year-end total equity) %6.4738.017.259.279.10
ROE (owners' profit / average owners' equity) %6.7442.957.519.509.50
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.